K

Sofinnova Partners logo

Sofinnova Partners

Crunchbase
Pitchbook
Crunchbase

Deals on record

16

Common Fundraising Type

Equity

BioClec logo
BioClec

Biotechnology • Microglia

Sofinnova Partners logo

BioClec is a biotechnology company that develops innovative therapies targeting microglia to treat Alzheimer's disease.

Equity
Undisclosed
03/19/2025
Article
Signadori Bio logo
Signadori Bio

Cell therapy • Cancer treatment

Sofinnova Partners logo

Signadori Bio is a biotech company developing a novel cell therapy platform to improve cancer treatment.

Equity
Undisclosed
03/19/2025
Article
Forth Tx logo
Forth Tx

Biotechnology • Precision Therapeutics

Sofinnova Partners logo
Old College Capital logo

Forth Therapeutics is a biotechnology company developing precision therapeutics for fibrosis using advanced omics technology and a significant single-cell human liver disease dataset.

Equity
Undisclosed
03/18/2025
Article
Berry Street logo
Berry Street

Nutrition counseling • Registered dieticians

Sofinova logo
Northzone logo
FJ Labs logo

Berry Street is a nutrition counseling platform that supports registered dieticians in managing independent practices and facilitates access to insurance-covered dietician services for individuals.

Equity
$50M
02/05/2025
Article
nChroma Bio logo
nChroma Bio

Epigenetic editing • Genetic medicines

Wilson Sonsini Goodrich & Rosati logo
Wellington Management logo
T. Rowe Price logo
Sofinnova Partners logo

nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.

Equity
$75M
12/11/2024
Article
Elicit Plant logo
Elicit Plant

Agri-biotech • Biosolutions

Elicit Plant is an agri-biotech company that develops phytosterol-based solutions to reduce water usage in broadacre crops by 20%.

Series B
$48M
11/14/2024
Article
Purespring Therapeutics logo
Purespring Therapeutics

Gene therapy • Kidney diseases

Sofinnova Partners logo
Syncona Limited logo
Gilde Healthcare logo
Forbion logo

Purespring Therapeutics is a gene therapy company specializing in developing treatments for kidney diseases using a proprietary adeno-associated viral (AAV) platform.

Series B
$104.8M
10/09/2024
Article
Arzeda logo
Arzeda

AI • Protein design

Sofinnova Partners logo
Sucden Ventures logo
Silver Blue logo
Lewis & Clark Agrifood logo

Arzeda uses AI to design proteins and enzymes for applications in food, home care, and materials.

Equity
$38M
09/17/2024
Article
Novameat logo
Novameat

Sustainable food technology • Plant-based products

Sofinnova Partners logo
Unovis Asset Management logo
Rubio Impact Ventures logo
Praesidium logo

Novameat develops innovative plant-based food products with a unique fibrous texture using proprietary technology to meet the demand for healthier and sustainable food options.

Series A
$19.2M
09/12/2024
Article
Freya Biosciences logo
Freya Biosciences

Biotech • Women's Reproductive Health

Freya Biosciences is a biotech company advancing women's reproductive health through the development of vaginal microbial immunotherapeutics for infertility associated with dysbiotic vaginal microbiota in patients undergoing assisted reproductive technology.

Series A
$38M
12/12/2023
Article
T-Therapeutics logo
T-Therapeutics

Biotech • TCR Therapeutics

Sofinnova Partners logo
University of Cambridge logo
Sanofi Ventures logo
F-Prime Capital logo

T-Therapeutics is a biotech firm specializing in developing TCR therapeutics for cancer and inflammatory disorders using their proprietary OpTiMus® platform.

Series A
$59.6M
11/16/2023
Article
L’ecole AI logo
L’ecole AI

AI Technology • Machine Teaching

Sofinnova Partners logo
Preston-Werner Ventures logo

L'école AI has developed "Machine Teaching" technology that simplifies the engineering complexity of deep-learning systems for computer vision, specifically in the field of image analysis, and aims to enable medical professionals and researchers to create customized AI systems to assist in their respective areas of expertise.

Seed
$3M
10/26/2023
Article
Betteromics logo
Betteromics

Digital Medicine • AI

Triatomic Capital logo
Sofinnova Partners logo
SHAKTI logo

Betteromics is a digital medicine pioneer that has developed a clinical-grade compliant Software-as-a-Service platform, Omics AI Cloud, which utilizes AI and computational techniques to empower life sciences professionals by eliminating data silos and allowing them to analyze multi-modal, multi-omics data in one place.

Series A
$20M
10/26/2023
Article
Bon Vivant logo
Bon Vivant

Precision Fermentation • Animal-Free Milk Proteins

Sofinnova Partners logo
Sparkfood logo
Captech Santé logo
Picus Capital logo

Bon Vivant is a precision fermentation startup that uses biotech techniques to reprogram yeast microorganisms and produce animal-free milk proteins with a lower environmental footprint, aiming to be a supplier to the food industry rather than a competitor.

Seed
$15.9M
10/12/2023
Article
Sitryx Therapeutics logo
Sitryx Therapeutics

Biopharmaceutical • Immunometabolism

GSK logo
SV Health Investors logo
Sofinnova Partners logo
Oxford Science Enterprises logo

Sitryx Therapeutics is a biopharmaceutical company that develops disease-modifying therapeutics for chronic autoimmune and inflammatory diseases by targeting and regulating cell metabolism.

Equity
$39M
09/27/2023
Article
Gradient Denervation Technologies logo
Gradient Denervation Technologies

Medical Device • Pulmonary Hypertension Treatment

Asabys Partners logo
Sofinnova Partners logo
Thuja Capital logo

Gradient Denervation Technologies is a medical device company that develops an ultrasound-based catheter device for the treatment of pulmonary hypertension.

Series A
$15M
09/07/2023
Article